MedPath

HYPAQUE SODIUM 50% - LIQ IV

HYPAQUE SODIUM 50% - LIQ IV

Discontinued
DIN Number

02180650

Drug Class

Human

Market Date

Apr 22, 1998

Company
HC

nycomed imaging a.s.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02180650
AIG Number0101806001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AA01 DIATRIZOIC ACID
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIATRIZOATE SODIUMActive
Strength: 50 %
Monograph: DIATRIZOATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.